150 related articles for article (PubMed ID: 14600569)
61. Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication.
Palmer BE; Boritz E; Blyveis N; Wilson CC
J Virol; 2002 Jun; 76(12):5925-36. PubMed ID: 12021325
[TBL] [Abstract][Full Text] [Related]
62. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
Larsson M; Jin X; Ramratnam B; Ogg GS; Engelmayer J; Demoitie MA; McMichael AJ; Cox WI; Steinman RM; Nixon D; Bhardwaj N
AIDS; 1999 May; 13(7):767-77. PubMed ID: 10357375
[TBL] [Abstract][Full Text] [Related]
63. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.
Sáez-Cirión A; Lacabaratz C; Lambotte O; Versmisse P; Urrutia A; Boufassa F; Barré-Sinoussi F; Delfraissy JF; Sinet M; Pancino G; Venet A;
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6776-81. PubMed ID: 17428922
[TBL] [Abstract][Full Text] [Related]
64. CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro.
Kinter AL; Horak R; Sion M; Riggin L; McNally J; Lin Y; Jackson R; O'shea A; Roby G; Kovacs C; Connors M; Migueles SA; Fauci AS
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):438-50. PubMed ID: 17411377
[TBL] [Abstract][Full Text] [Related]
65. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
[TBL] [Abstract][Full Text] [Related]
66. Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function.
Palmer BE; Boritz E; Wilson CC
J Immunol; 2004 Mar; 172(5):3337-47. PubMed ID: 14978142
[TBL] [Abstract][Full Text] [Related]
67. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
[TBL] [Abstract][Full Text] [Related]
68. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
[TBL] [Abstract][Full Text] [Related]
69. Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection.
Alatrakchi N; Damond F; Matheron S; Beretta-Tempelhoff S; Campa P; Carcelain G; Brun-Vezinet F; Autran B;
AIDS; 2006 Jan; 20(1):29-34. PubMed ID: 16327316
[TBL] [Abstract][Full Text] [Related]
70. HIV rebound after discontinuation of antiretroviral therapy increases and expands HIV-specific CD8+ responses but has no impact on its functionality.
López M; Rallón N; Soriano V; Rodríguez I; Valencia E; Labarga P; Moreno V; Vispo E; Roncal F; González-Lahoz J; Benito JM
AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1197-201. PubMed ID: 18788910
[TBL] [Abstract][Full Text] [Related]
71. CD8
Kim J; De La Cruz J; Lam K; Ng H; Daar ES; Balamurugan A; Yang OO
Viral Immunol; 2018 Sep; 31(7):525-536. PubMed ID: 30059271
[TBL] [Abstract][Full Text] [Related]
72. Quantification of HIV-specific CD8 T cells by in vitro stimulation with inactivated viral particles.
Xu J; Whitman L; Lori F; Lisziewicz J
AIDS; 2002 Sep; 16(14):1849-57. PubMed ID: 12351944
[TBL] [Abstract][Full Text] [Related]
73. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
[TBL] [Abstract][Full Text] [Related]
74. Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort.
Kapogiannis BG; Henderson SL; Nigam P; Sharma S; Chennareddi L; Herndon JG; Robinson HL; Amara RR
AIDS Res Hum Retroviruses; 2006 Mar; 22(3):272-82. PubMed ID: 16545014
[TBL] [Abstract][Full Text] [Related]
75. An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.
D'Offizi G; Gioia C; Corpolongo A; Martini F; Paganelli R; Volpi I; Sacchi A; Tozzi V; Narciso P; Poccia F
Int J Immunopathol Pharmacol; 2007; 20(3):473-85. PubMed ID: 17880761
[TBL] [Abstract][Full Text] [Related]
76. Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection.
Malhotra U; Holte S; Zhu T; Delpit E; Huntsberry C; Sette A; Shankarappa R; Maenza J; Corey L; McElrath MJ
J Virol; 2003 Feb; 77(4):2663-74. PubMed ID: 12552005
[TBL] [Abstract][Full Text] [Related]
77. Immune reconstitution and viral stimulation are required to restore HIV-specific CD8 T cell responses following advanced infection.
Gamberg J; Barrett L; Bowmer I; Howley C; Grant M
J Clin Immunol; 2004 Mar; 24(2):115-24. PubMed ID: 15024178
[TBL] [Abstract][Full Text] [Related]
78. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
[TBL] [Abstract][Full Text] [Related]
79. Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses.
Yu XG; Shang H; Addo MM; Eldridge RL; Phillips MN; Feeney ME; Strick D; Brander C; Goulder PJ; Rosenberg ES; Walker BD; Altfeld M;
AIDS; 2002 Feb; 16(3):321-8. PubMed ID: 11834942
[TBL] [Abstract][Full Text] [Related]
80. Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.
Lopes AR; Jaye A; Dorrell L; Sabally S; Alabi A; Jones NA; Flower DR; De Groot A; Newton P; Lascar RM; Williams I; Whittle H; Bertoletti A; Borrow P; Maini MK
J Immunol; 2003 Jul; 171(1):307-16. PubMed ID: 12817012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
